Vagus nerve stimulation for epilepsy

Clinical Neuroscience Research

Volumn 4, Issue 1-2, 2004, Pages 81-87

  Labar, Douglas ^a  

^a New York Presbyterian Cornell ^*  (United States)

Author keywords

Epilepsy; Vagus nerve stimulation

Indexed keywords

ANTICONVULSIVE AGENT;

ADD ON THERAPY; ARTICLE; ASYSTOLE; BRADYCARDIA; BRAIN BLOOD FLOW; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION LOSS; COUGHING; DISEASE DURATION; DISEASE EXACERBATION; DYSPEPSIA; DYSPNEA; FATIGUE; FOCAL EPILEPSY; FOLLOW UP; GENDER; GENERALIZED EPILEPSY; HEADACHE; HOARSENESS; HUMAN; IMPLANT; LENNOX GASTAUT SYNDROME; LONG TERM CARE; NAUSEA; NEUROMODULATION; PARESTHESIA; PHARYNGITIS; PREDICTION; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TREATMENT FAILURE; VAGUS NERVE STIMULATION;

EID: 17644380269     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2004.06.007     Document Type: Article

References (52)

1. Penry J. Dean J. Prevention of intractable partial seizures by intermittent VNS in humans: Preliminary results Epilepsia 31 Suppl 2 1990 S40-S43
2. Fischer R. Handforth A. Reassessment: VNS for epilepsy Neurology 53 1999 666-669
3. Salinsky M. Wernicke J. Rutecki P. George R. Sonnen A. Upton A. et al. A randomized controlled trial of chronic VNS for treatment of medically intractable seizures Neurology 45 1995 224-230
4. Handforth A. DeGiorgio C. Schachter S. Uthman B.M. Naritoku D.K. Tecoma E.S. et-al VNS therapy for partial-onset seizures Neurology 51 1998 48-55
5. Asakura T. Nakamura K. Yatsushiro K. Shimizu H. Ishijima B. Otsuki T. et-al Effect of VNS on intractable epilepsy First trial in Japan Presented at the Third European Congress of Epileptology, Warsaw, Poland, May 24-29 1998
6. Lundgren J. Amark P. Blennow G. Stromblad L. Wallstedt L. VNS in 16 children with refractory epilepsy Epilepsia 39 1998 809-813
7. Parker A. Polkey C. Binnie C. Madigan C. Ferrie C. Robinson R. VNS in epileptic encephalopathies Pediatrics 103 1999 778-782
8. Murphy J. Andriola M. Barron T. Burgerman R. George R. Gilmartin R.et-al Left VNS in children with medically refractory epilepsy J Pediatr 134 1999 563-566
9. Patwardan R. Strong B. Bebin M. Mathisen J. Grabb P. Efficacy of VNS in children with medically refractory epilepsy Neurosurgery 47 2000 1353-1358
10. Helmers S. Wheless J. Frost M. Gates J. Levisohn P. Tardo C. et-al VNS therapy in pediatric patients with refractory epilepsy: retrospective study J Child Neurol 16 2001 843-848
11. Hosain S. Nikolov W. Harden C. Li M. Fraser R. Labar D. VNS treatment for the LGS J Child Neurol 15 2000 509-512
12. Aldenkamp A. Van de Veerdonk S. Majoie H. Berfelo M. Evers S. Kessels A. et-al Effects of 6 months treatment with VNS on behavior in children with LGS in an open clinical and nonrandomized study Epilepsy Behav 2 2001 343-350
13. Frost M. Gates J. Helmers S. Whelers J.M. Levisohn P. Tardo C. et-al VNS in children with refractory seizures associated with LGS Epilepsia 42 2001 1148-1152
14. Karceski S. VNS and LGS: A review of the literature and data for the VNS patient registry CNS Spectr 6 2001 766-770
15. Majoie H. Berfola M. Aldenkamp A. Evers S. Kessels A. Renier W. et-al VNS in children with therapy-resistant epilepsy diagnosed as LGS J Clin Neurophys 18 2001 419-428
16. Labar D. Antiepileptic drug use during the first 12 months of vagus nerve stimulation therapy Neurology 59 Suppl 4 2002 S38-S43
17. Tatum W. Johnson K. Goff B. Ferreira J. Benbadis S. Vale F. VNS and drug reduction Neurology 56 2001 561-563
18. Morris G. Mueller W. Andriola M. Ben-Manachem E. Casey K. Collins S. et al. Long-term treatment with VNS in patients with refractory epilepsy Neurology 53 1999 1731-1735
19. DeGiorgio C. Thompson J. Lewis P. Arrambide S. Naritoku S. Handforth A. et-al VNS: Analysis of device parameters in 154 patients during the long-term XE5 study Epilepsia 42 2001 1017-1020
20. Ben-Menachem E. Hellstrom K. Waldton C. Augustinsson L. Evaluation of refractory epilepsy treated with VNS for up to 5 years Neurology 52 1999 1265-1267
21. Vonck K. Boon P. D'Have M. Vandekerckhove T. O'Connor S. De Reuck J. Long-term results of VNS in refractory epilepsy Seizure 8 1999 328-334
22. Labar D. VNS for 1 year in 269 patients on unchanged antiepileptic drugs Seizure 2004 in press
23. Labar D. Ponticello L. Persistent antiepileptic effects after VNS ends? Neurology 61 2003 1818
24. Labar D. Murphy J. Tecoma E. Sala D. Burgerman R. Gilmartin R. et-al VNS for medication-resistant generalized epilepsy Neurology 52 1999 1510-1512
25. Sirvin J. Sperling M. Naritoku D. Schachter S. Labar D. Holmes M. et-al VNS for epilepsy in older adults Neurology 54 2000 1179-1182
26. Murphy J. Wheless J. Schmoll C. Left VNS in six patients with hypothalamic hamartomatas Pediatr Neurol 23 2000 167-168
27. Smith B. Shatz R. Elisevich K. Bespalova I. Burmeister M. Effects of VNS on progressive myoclonus epilepsy of Unverricht-Lundberg type Epilepsia 41 2000 1046-1048
28. Alsaadi T. Laxer K. Barbaro N. Marks W. Garcia P. VNS for the treatment of bilateral temporal lobe epilepsy Epilepsia 42 2001 954-956
29. Winston K. Levisohn P. Miller B. Freeman J. VNS for status epilepticus Pediatr Neurosurg 34 2001 190-192
30. Gates J. Huf R. Frost M. VNS for patients in residential facilities Epilepsy Behav 2 2001 563-567
31. Annegers J. Coan S. Hauser W. Leestma J. Epilepsy, VNS by the NCP system, all-cause mortality, and SUDEP Epilepsia 41 2000 549-553
32. Harden C. Pulver M. Ravdin L. Nikolov B. Halper J. Labar D. A pilot study of mood in epilepsy patients treated with VNS Epilepsy Behav 1 2000 93-99
33. Elger G. Hoppe C. Falkai P. Rush J. Elger C. VNS is associated with mood improvements in epilepsy patients Epilepsy Res 42 2000 203-210
34. Clark K. Naritoku D. Smith D. Browning R. Jensen R. Enhanced recognition memory following VNS in human subjects Nat Neurosci 2 1999 94-98
35. Burneo J. Faught E. Knowlton R. Morawetz R. Kuzniexky R. Weight loss associated with VNS Neurology 2002 463-464
36. Liporace J. Hucko D. Morrow R. Barolot G. Nei M. Schnur B. et-al VNS: Adjustments to reduce painful side effects Neurology 57 2001 885-886
37. Lundgren J. Ekkberg O. Olssson R. Aspiration: A potential complication to VNS Epilepsia 39 1998 998-1000
38. Schallert G. Foster J. Lindquist N. Murphy J. Chronic stimulation of the left vagus nerve in children; effect on swallowing Epilepsia 39 1998 1113-1114
39. Leijten F. Van Rijen P. Stimulation of the phrenic nerve as a complication of vagus nerve pacing in a patient with epilepsy Neurology 51 1998 1224-1225
40. Koutroumanidis M. Henessy M. Binnnie C. Polkey C. Aggravation of partial epilepsy and emergence of new seizure type during treatment with VNS Neurology 55 2000 892-893
41. Malow B. Edwards J. Marzec M. Sagher O. Frommes G. Effects of VNS on respiration during sleep Neurology 55 2000 1450-1454
42. Gatzonis S. Stamboulis E. Siafakas A. et-al Acute psychosis and EEG normalization after VNS J Neurol Neurosurg Psychiatry 69 2000 278-279
43. Tatum W. Moore D. Stecker M. Baltuch G.H. French J.A. Ferreira J.A. et-al Ventricular asystole during VNS for epilepsy in humans Neurology 52 1999 1267-1269
44. Asconape J. Moore D. Zipes D. Hartment L. Duffell W. Bradycardia and asystole with use of VNS for the treatment of epilepsy: a rare complication of intraoperative device testing Epilepsia 40 1999 1452-1454
45. Setty A. Vaughn B. Quint S. Robertson K. Messenheimer J. Heart period variability during VNS Seizure 7 1998 213-217
46. Frei M. Osorio I. Left VNS with the NCP has complex effects on heart rate and on its variability in humans Epilepsia 42 2001 1007-1016
47. Renfroe J. Wheless J. Earlier use of adjunctive VNS therapy for refractory epilepsy Neurology 59 Suppl 4 2002 S26-S31
48. Wernicke J. Holder L. Keenan S. Lunney S. Tarver B. Response predictors for VNS in the treatment of refractory partial epilepsy Epilepsia 33 Suppl 3 1992 S1010
49. Henry T. Votaw J. Pennell P. Epstein C.M. Bakay R.A. Faber T.L. et-al Acute blood flow changes and efficacy of VNS in partial epilepsy Neurology 52 1999 1166-11730
50. Hornig G. Murphy J. Schallert G. Tilton C. Left VNS in children with refractory epilepsy South Med J 90 1997 481-488
51. Tarver B. VNS clinical studies-predictors of response PMAA/USFDA presentation 1997
52. Labar D. VNS: Effects on seizures In: Luders H. editors Brain stimulation and epilepsy 2004 Martin Dunitz London